МЕТОТРЕКСАТ В ТЕРАПИИ ЮВЕНИЛЬНЫХ ХРОНИЧЕСКИХ АРТРИТОВ

1. <div><p>узьмина Н.Н. Брюэр Э„ Шайков А.В. и др. Оценка терапевтической эффективности и переносимости различных доз метотрексата при ЮРА. Клинич. ревматол., 1994. 1. 3-7.</p><p>Кузьмина Н.Н., Шайков А.В. Ювенильный ревматоидный артрит: терминологические и классификационные аспекты. Научно-практич. ревматол. 2000, 1, 35-41,</p><p>Кузьмина Н.Н., Никишина И.П. Комплексная терапия ювенильных спондилоартритов: алгоритм лечебной программы. Междунар. журнал практики, 2000. 4, 7-8.</p><p>Лашнна Н.Ю., Асеева Е.А., Соловьев С.К. Эффективность пульс-тералии глюкокортикостероидами и метотрексатом при ревматоидном артрите. Научно-практич. ревматол. 2000. 1. 55-60.</p><p>Лоуэлл Д. Десятилетний опыт применения метотрексата. Прошедшее, настоящее, будущее. Детская ревма- тол., 1997. 3. 32-36.</p><p>Максимов А.А. Пульс-терапия метипредом в сочетании с циклофосфаном в плановом, комплексном лечении детей на ранней стадии системного ЮРА. Автореф. к.м.н. М., 1992, 25.</p><p>Михельс X. Терапия рефрактерного ювенильного хронического артрита. Научно-практич. ревматол. 2001, 2. 31-36.</p><p>Насонов ЕЛ., Соловьев С.К. Применение метотрексата в ревматологии. М., 2000, 128.</p><p>Пуринь В.И. Диагноз, лечение и прогноз хронических артритов у детей. Автореф. д.м.н. С-Петербург, 1999. 45.</p><p>Снгндин Я.А. Лукина Г.В. Базисная (патогенетическая) терапия ревматоидного артрита. Серия "Аутоиммунные болезни” № I, Novartis, 2000, 100.</p><p>Соловьев С.К., Иванова М.М., Насонов Е.Л. Интенсивная терапия ревматических заболеваний. Пособие для врачей. М., "МИК", 2001, 40.</p><p>Шайков А.В. Ювенильный ревматоидный артрит. В книге Ревматические болезни. Руководство по внутренним болезням. Под ред. В.А. Насоновой и Н.В. Бунчука. М., «Медицина*, 1997, 295-304.</p><p>Шахбазян И.Е., Алексеева Е.И. Протокол лечения ювенильного ревматоидного артрита. Междунар. журнал практики, 2000, 4, 9-11.</p><p>Щербакова М.Ю. Реаферон в комплексной терапии ювенильного ревматоидного артрита. Автореф. к.м.н. М., 1992, 25.</p><p>Aguirre М.А., Velez A, Romero М. et al. Gynecomastia and sexual impotence associated with methotrexate treatment. J. Rheumatol. 2002, 29(8), 1793-1794.</p><p>Aibertioni F., Rato B., Seideman P. et al. Methotrexate in juvenile rheumatoid arthritis. Evidence of age dependent pharmacokinetics. Eur.Г. Clin, Pharmacol. 1995. 47 (6). 507-511.</p><p>Andersen L.S. Hansen E.L. Knudsen.I B. et al. Prospectively measured red cell folate levels in methotrexate treated patients with rheumutoid arthritis: relation to withdrawal and side effects. J. Rheumatol. 1997, 24(5), S30-S37.</p><p>Baggott J.E. Morgan S.L., Ha T.S. et al. Inhibition of folate-dependent enzymes by non-steroidal anti-inflammatory druds. Biochem. J., 1992. 197-203.</p><p>Balis F.M., Mirro J.Jr., Reaman G.H. et al. Pharmacokinetics of subcutaneous methotrexate. J. Clin. Oncol. 1988, 6(12). 1882-1886.</p><p>Balis F.M., Savitch J.L., Bleyer W.A. Pharmacokinetics of oral methotrexate in children. Cancer Res. 1983, 43(5), 2342-2345.</p><p>Barrera P., Boerbooms A.M., Janssen E.M. et al. Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapv. Arthr. Rheum. 1993, 36(8). 1070-1079.</p><p>Bertin P. Carpentier N. Vergne P. et al. Methotrexate and non-steroidal anti-inflammatory agent combination in rheumatoid arthritis. Therapie, 1997, 52(2), 133-137.</p><p>Bleyer W.A. Clinical pharmacology and therapeutic drug monitoring of methotrexate. Clin. Chem., 1985, 6.1-14.</p><p>Brik R. Methotrexate treatment in refractory juvenile rheumatoid arthritis. Harefuah., 1998, 1. 135 (11), 509-511.</p><p>Brion N., Paule B. Non-cancer uses of methotrexate. Presse Med., 1996, 14, 25(39). 1929-1934.</p><p>Carol F., Wallace C.A. The use of methotrexate in childhood rheumatic diseases. Arthr. Rheum., 1998. 41(3). 381391.</p><p>Cassidy J.T., Petty R.E. Juvenile rheumatoid arthritis. Textbook of pediatric rheumatology. 4th ed. W.B. Saunders Company, 2001.</p><p>Cream J.J., Poole D.S. The effect of methotrexate and hydroxyurea on neutrophil chemotaxis. Br. J. Dermatol. 1980, 102. 557-563.</p><p>Cron R.Q., Sherry D.D., Wallace C.A. Methotrexate- induced hypersensitivity pneumonitis in a child with juvenile rheumatoid arthritis. J. Pediatr., 1998, 132(5), 901-902.</p><p>Cronstein B.N. The mechanism of action of methotrexate. Rheum. Dis. Clin. North. Am., 1997, 23(4), 739-755.</p><p>Dupuis L.L., Koren G., Silverman E.D. et al. Influence of on the bioavailabilitv of oral methotrexate in children. J. Rheumatol., 1995, 22(8), 1570-1573.</p><p>Falcini F., Taccetti G., Ermini M. et al. Methotrexate- associated appearance and rapid progression of rheumatoid nodules in systemic-onset juvenile rheumatoid arthritis. Arthr. Rheum., 1997. 40(1), 175-178.</p><p>Gabriel S. Creagan E., O'Fallon W.M. et al. Treatment of rheumatoid arthritis with higher dose intravenous methotrexate. J. Rheumatol., 1990, 17(4). 460-465.</p><p>Giannini E.H., Cawkwell G.D. Drug treatment in children with juvenile rheumatoid arthritis. Past, present, and future. Pediatr. Clin. North. Am., 1995, 42(5). 1099-1125.</p><p>Giannini E.H., Cassidy J.T. Methotrexate in juvenile rheumatoid arthritis. Do the benefits outweigh the risks? Drug. Saf., 1993, 9(5), 325-339.</p><p>Giannini E.H., Cassidy J.T, Brewer E.J et al. Comparative efficacy and safety of advanced drug therapy in children with juvenile rheumatoid arthritis Semin. Arthr. Rheum., 1993, 23(1), 34-46.</p><p>Gottlieb B.S., Keenan G.F., Lu T. et al. Discontinuation of methotrexate treatment in juvenile rheumatoid arthritis. Pediatrics. 1997, 100(6). 994-997.</p><p>Graham L.D., Myones B.L., Rivas-Chacon R.F. et al. Morbidity associated with long-term methotrexate therapy in juvenile rheumatoid arthritis. J. Pediatr,, 1992, 120(3), 468-473.</p><p>Halle F., Prieur A.M. Evaluation of methotrexate in the treatment of juvenile chronic arthritis according ю the subtype. Cl. Exp. Rheumatol., 1991, 9, 297-302. ~</p><p>Harel L., Wagner-Weiner L., Posnanski A.K. et al. Effects of methotrexate on radiologic progression in juvenile rheumatoid arthritis. Arthr. Rheum. 1993, 36(10). 13701374.</p><p>Hashkes P.J., Balistreri W.F. Bove K.E. The long-term effect of methotrexate therapy on the liver in patients with juvenile rheumatoid arthritis. Anhr, Rheum., 1997,40(12), 2226-2234.</p><p>Hashkes P.J. Balistreri W,F,. Bove K.E. et al. The relationship of hepatotoxic risk factors and liver histology in methotrexate therapy for juvenile rheumatoid arthritis. J. Pediatr,, 1999, 134(1), 47-52.</p><p>Huang J.L. Methotrexate in the treatment of children with chronic arthritis - long-term observations of efficacy and safety. Br. J. Clin. Pract. 1996. 50(6). 311-314.</p><p>Hunt P.G. Rose C.D., Me Ilvain-Simpson G. et at. The effects of folic acid on the efficacy of methotrexate therapy in children with juvenile rheumatoid arthritis. A controlled study. J. Rheumatol. 1997. 24(11), 2230-2232</p><p>Ilowite NT. Current treatment of juvenile rheumatoid arthritis. Pediatrics, 2002, 109(1), 109-115. 4b. Job-Deslandre. Chkirate B. Treatment of refractory juvenile systemic arthritis (JSA) with cyclosporin A and methotrexate: an open study et 5 patients. Ann. Rheum. Dis. 2000, 59(9), 744.</p><p>Kiss M.N.B. Silva C.A.A. Miranda L. Methotrexate in juvenile rheumatoid arthritis. 4th European conference on pediatric rheumatology, 1996, 74.</p><p>Kozlovski G., De Vito J.M., Kisicki J.C. et al. The effect of food on the absorption of methotrexate sodium tablets in healthy volunteers. Arthr. Rheum., 1992, 35, 761-764.</p><p>Kremer J.M., Alarcon G.S., Lightfoot R.W. Jr. et al. Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. Arthr. Rheum., 1994, 37(3), 316-328.</p><p>Krugmann J. Sailer-Hock М. Muller T. et al. Epstein- Barr virus-associated Hodgkin s lympfoma and legionella pneumophila infection complicating treatment of juvenile rheumatoid arthritis with methotrexate and cvclosporine A. Hum. Pathol. 2000. 31(2), 253-255.</p><p>Lin Y.H., Tsai M.J., Wang L.H. et al. Efficacy and safety of methotrexate therapy for juvenile rheumatoid arthritis. J. Formos Med. Assoc., 2000. 99(8), 623-629.</p><p>Lovell D.J., Giannini E.H. ReifT A. et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis. N. Engl. J. Med. 2000. 16, 342(11). 763-769.</p><p>Massa М., de Benedetti F., Robbioni P. et al. Association of methotrexate treatment with a decrease of double negative (CD4-CD8-) end gamma/delta T cell levels in patients with juvenile rheumatoid arthritis. J. Rheumatol., 1993, 20 (11), 1944-1948.</p><p>Mier R., Lovell D., Bowyer S. et al. Medication choices in juvenile rheumatoid arthritis. J. Clin. Rheumatol. 1996. 2, 262-267.</p><p>Muzaffer M.A., Scheider R., Cameron B.J. et al. Accelerated nodulosis during methotrexate therapy for juvenile rheumatoid arthritis. J. Pediatr., 1996, 128(5), 698700.</p><p>Nesher G., Osborn T.G. Moore T.L. Effect of treatment with methotrexate, hydroxychloroquine, and prednisone on lymphocyte polyamine levels in rheumatoid arthritis: correlation with the clinical response and rheumatoid factor synthesis. Clin. Exp. Rheumatol., 1997, 15(4), 343-347.</p><p>Olsen N.J., Callahan L.F., Pincus T. Immunologic studies of rheumatoid arthritis patients treated with methotrexate. Arthr. Rheum., 1987. 30, 4811-4818.</p><p>Padeh S., Sharon N. Schiby G. et al. Hodgkin's lymphoma in systemic onset juvenile rheumatoid arthritis after treatment with low dose methotrexate. J. Rheumatol., 1997. 24(10), 2035-2037.</p><p>Pelucchi A., Lomater C., Gerloni V. et al. Lung function and diffusing capacity for carbon monoxide in patients with juvenile chronic arthritis: effect of disease activity and low dose methotrexate therapy. Clin. Exp. Rheumatol. 1994, 12(6), 675-679.</p><p>Rackham O.J., Sills J.A., Davidson J.E. Immunoglobulin levels in methotrexate treated paediatric rheumatology patients. Arch. Dis. Child., 2002, S7(2), 147-148.</p><p>Ranaviene V., Garhauskiene A., Jakutoviche M, Methotrexate combined with sulphasalazine in the treatment of juvenile rheumatoid arthritis. 4th European conference on pediatric rheumatology. 1996. 76.</p><p>Ravelli A., Di Fuccia G., Molinaro M. et al. Plasma levels after oral methotrexate in children with juvenile rheumatoid arthritis. J. Rheumatol., 1993, 20(9). 1573-1577.</p><p>Ravelli A., Gerloni V. Corona F. et al. Oral versus intramuscular methotrexate in juvenile chronic arthritis. Cl. Exp. Rheumatol. 1998. 16(2). 181-183.</p><p>Ravelli A., Migliavacca D., Viola S. et al. Efficacy offolin- ic acid in reducing methotrexate toxicity in juvenile idiopathic arthritis. Clin. Exp. Rheumatol. 1999. 17(5), 625627.</p><p>Ravelli A., Ramenghi B. Di Fuccia G. ct al. Factors associated with response lo methotrexate in systemic onset juvenile chronic arthritis. Acta Paediatr., 1994. 83(4). 428432.</p><p>Ravelli A., Viola S., Migliavacca D. et al. The extended oligoarticular subtype is the best predictor of methotrexate efficacy In juvenile idiopathic arthritis. J. Pediatr., 1999, 135(3), 316-320.</p><p>Ravelli A. Viola S. Ramenghi B. et al. Frequency of replase after discontinuation of methotrexate therapy for clinical remission in juvenile rheumatoid arthritis. J. Rheumatol. 1995, 22(8). 1574-1576.</p><p>Ravelli A., Viola S., Ramenghi B. et al, Radiologic progression in patients with juvenile chronic arthritis treated with methotrexate. J. Pediatr. 1998. 133(2). 262-265.</p><p>Reiff A„ Shaham B. Wood B.P. et al. High dose methotrexate in the treatment of refractory juvenile rheumatoid arthritis. Clin. Exp. Rheumatol., 1995, J3(l), 113-118.</p><p>Rose C.D. Fawcett P.T. Gibney K. el al. Serial measurements of soluble interleukin-2 receptor levels (slL2-R) in children with juvenile rheumatoid arthritis treated with oral methotrexate. Ann. Rheum. Dis., 1994. 53(7), 471-474.</p><p>Rose C.D. Singsen B.H. Eichenfield A.H. et al. Safety and efficacy of methotrexate therapy for juvenile rheumatoid arthritis. J. Pediatr., 1991. 118(6), 992-993.</p><p>Ruperto N. Murray K.J., Gerloni V. et al. A randomized trial of methotrexate in medium versus Higher doses in children with juvenile idiopathic arthritis who failed on standard dose. Ann. Rheum. Dis. Annal European Congress of Rheumatology EULAR. Stocholm, 2002, 61 suppl I, 60.</p><p>Scarazatti М. Corona F., Mazarese M. Safely of intramus- colar Iow'-dose MTX in JCA: a long-term prospective study. 4th European conference on pediatric rheumatology. 1996,</p><p>Schmeling H. Mathony K. John V. et al. A combination of etanercept and methotrexate for the treatment of refractory juvenile idiopathic arthritis: a pilot studv. Ann. Rheum. Dis., 2001. 60(4). 410-412.</p><p>Schmeling H., Stephan V., Burdach S. et al. Pulmonary function in children with juvenile idiopathic arthritis and effects of methotrexate therapy. Z. Rheumatol., 2002. 61(2), 168-172.</p><p>til-Sewairy W„ al-Mazyed A. al-Dalaan et al. Methotrexate therapy in systemic-onset juvenile rheumatoid arthritis in Saudi Arabia: a retrospective analysis. Clin. Rheumatol., 1998. 17(1), 52-57.</p><p>Shiroky J. Allegra C., Inghirami G. et al. High dose intravenous methotrexate with leucovorin rescue in rheumatoid arthritis. J. Rheumatol., 1988, 15(2), 251-255.</p><p>Speckmaier М., Findeisen J., Woo P. et al. Low-dose methotrexate in systemic onset juvenile chronic arthritis. Clin. Exp. Rheumatol. 1989, 7(6), 647-650.</p><p>Teresi M.E., Crom W.R., Choi K.E. et al. Methotrexate bioavailabilitv after oral and intramuscular administration in children. J. Pediatr. 1987, 110(5), 788-792.</p><p>Truckenbrodt H. Hafner R. Methotrexate therapy in juvenile rheumatoid arthritis: a retrospective studv. Arthr, Rheum., 1986. 29, 801-807.</p><p>Wallace C.A. The use of methotrexate in childhood rheumatic diseases. Arthr. Rheum. 1998, 41(3), 381-391.</p><p>Wallace C.A., Bleyer W.A., Sherry D.D. et al. Toxicity and serum levels of methotrexate in children with juvenile rheumatoid arthritis. Arthr. Rheum., 1989, 32(6), 677-681</p><p>Wallace C.A., Sherry D.D. Preliminary report of higher dose methotrexate treatment in juvenile rheumatoid arthritis. J. Rheumatol., 1492. 19(10). 1604.</p><p>Wallace C.A. Sherry D.D. Trial of intravenous pulse cyclophosphamide and methylprednisolone in the tretment of severe svstemic-onset juvenile rheumatoid arthritis. Arthr. Rheum., 1997, 40(10), 1854-1855.</p><p>Wallace C.A., Sherry D.D., Mellins E.D. et al. Predicting remission in juvenile rheumatoid arthritis with methotrexate treatment. J. Rheumatol., 1993, 20(1), 118-122.</p><p>Wallace C.A., Smith A.L., Sherry D.D. Pilot investigation of naproxen/ methotrexate interaction in patients with juvenile rheumatoid arthritis. J. Rheumatol., 1993, 20(10), 1764-1768.</p><p>Woo P. Southwood T.R. Prieur A.M. et al. Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extende oligoarticular or systemic arthritis. Arthr. Rheum. 2000, 43 (8), 1849-1857.</p></div><br />